Chemotherapy Induced Peripheral Neuropathy Treatment Market 2020 and Forecast 2021-2027

  • TBI878673
  • November 07, 2020
  • Global
  • 144 pages
  • ROIF Expert
                                          

CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended. There are no approved therapies to combat the debilitating symptoms of CIPN now. Current alternatives include Palliative care using antidepressants, antiepileptic drugs, or opioids, all of which have well known adverse side effects. By region, the United States has the highest share of income, reaching 47.25 percent in 2019. Market Analysis and Insights: Global Chemotherapy Induced Peripheral Neuropathy Treatment Market The global Chemotherapy Induced Peripheral Neuropathy Treatment market size is projected to reach US$ 2276.6 million by 2026, from US$ 1572.6 million in 2020, at a CAGR of 6.4% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chemotherapy Induced Peripheral Neuropathy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chemotherapy Induced Peripheral Neuropathy Treatment market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chemotherapy Induced Peripheral Neuropathy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chemotherapy Induced Peripheral Neuropathy Treatment market.

Chemotherapy Induced Peripheral Neuropathy Treatment Breakdown Data by Type

  • Calcium Channel Alpha2-delta Ligands
  • Antidepressants
  • Opioids
  • Others

Chemotherapy Induced Peripheral Neuropathy Treatment Breakdown Data by Application

  • Platinum Agents
  • Taxanes
  • Vinca Alkaloids
  • Others
In the competitive analysis section of the report, leading as well as prominent players of the global Chemotherapy Induced Peripheral Neuropathy Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The following players are covered in this report:

  • Aptinyx Inc
  • Asahi Kasei Pharma Corp
  • Regenacy Pharmaceuticals
  • MAKScientific LLC
  • Metys Pharmaceuticals AG
  • Nemus Bioscience Inc
  • PledPharma
  • Sova Pharmaceuticals Inc
  • DermaXon LLC
  • Kineta Inc
  • Krenitsky Pharmaceuticals Inc
  • PeriphaGen
  • Apexian Pharma
  • WinSanTor
  • Solasia Pharma K.K.

This research comprehensively answers the following 9 important questions:

  • Q.1. What are some of the most promising growth trends in the Chemotherapy Induced Peripheral Neuropathy Treatment market worldwide?
  • Q.2.Which segments and sub-segments will grow at a faster pace and why? Which segment is nearing the peak and demand saturation?
  • Q.3.Which region will witness a higher growth rate and why? Which region might see a slower or negative growth region?
  • Q.4.What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Chemotherapy Induced Peripheral Neuropathy Treatment market?
  • Q.5.What are the business risks and who pose challenges to the global leaders and are competitive threats in this Chemotherapy Induced Peripheral Neuropathy Treatment market?
  • Q.6.What are the emerging trends post COVID-19 reshuffle in this Chemotherapy Induced Peripheral Neuropathy Treatment market and the what are reasons behind these trends and do they translate in global exploration?
  • Q.7. Who are the major global and regional players in the Chemotherapy Induced Peripheral Neuropathy Treatment market? Which are the strategic initiatives key players are pursuing for business growth?
  • Q.8.Which are the competing products in Chemotherapy Induced Peripheral Neuropathy Treatment market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.9.What M & A activity has occurred in the last 5 years and what is its impact on the Chemotherapy Induced Peripheral Neuropathy Treatment industry?

Table of Contents

Chapter 1. Preface
	
		1.1. Report Description
		
			1.1.1. Objective
			1.1.2. Target Audience
			1.1.3. Unique Selling Proposition (USP) & Offerings
		
		
		1.2. Research Scope
		1.3. Research Methodology
		
			1.3.1. Market Research Process
			1.3.2. Market Research Methodology
			1.3.3. Level 1: Primary Research
			1.3.4. Level 2: Secondary Research
			1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
			
Chapter 2. Executive Summary
	
		2.1. Global Chemotherapy Induced Peripheral Neuropathy Treatment 2019-2029 (USD Billion)
		2.2. Global Chemotherapy Induced Peripheral Neuropathy Treatment: Market Snapshot
	 
Chapter 3. Global Chemotherapy Induced Peripheral Neuropathy Treatment - Industry Analysis
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form